Prostanoid EP2 Receptors Are Up-Regulated in Human Pulmonary Arterial Hypertension: A Key Anti-Proliferative Target for Treprostinil in Smooth Muscle Cells
Jigisha Patel(University College London), Lucie H. Clapp(The London College), Shahin Moledina(Great Ormond Street Hospital), Adam M. Silverstein(United Therapeutics (United States)), Robin J. McAnulty(University College London), Brendan J.R. Whittle(Wellcome Trust), Lei Shen(University College London), Xavier Norel(Inserm), Susan Hall(Immune Regulation (United Kingdom)), Chabha Benyahia(Inserm)
Cited by 34
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Identification of rare sequence variation underlying heritable pulmonary arterial hypertension
|Nature Communications|2018|382
Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2019|343
Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study
|The Lancet Respiratory Medicine|2017|299